Masimo | MASI - Cost Of Sales

Stock Price
175.49
Daily Change
0.27 0.15%
Monthly
27.24%
Yearly
-5.75%
Q1 Forecast
169.67

Masimo reported $140.9M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 363.97M 7.48M Dec/2025
AngioDynamics USD 33.15M 208K Feb/2025
Artivion USD 34.77M 75K Sep/2024
AtriCure USD 35.16M 2.23M Dec/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
General Electric Aerospace USD 8.92B 654M Dec/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.61B 83M Dec/2025
Orthofix International USD 253.61M 192.05M Dec/2024
Owens Minor USD 2.11B 10.27M Mar/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025